Business

Orphan Drug designation from FDA for ATL1103 in Acromegaly

Orphan Drug designation from FDA for ATL1103 in Acromegaly

articlePercheron Therapeutics LimitedMay 12, 20163/company/percheron-therapeutics-limited/news/orphan-drug-designation-from-fda-for-atl1103-in-acromegaly
Orphan Drug designation from FDA for ATL1103 in Acromegaly

About this update from Percheron Therapeutics Limited

[{"type":"text","content":"Percheron Therapeutics Limited has released a press release. View Attachment","length":259,"tagName":"div"}]

More updates from Percheron Therapeutics Limited